Matches in SemOpenAlex for { <https://semopenalex.org/work/W1966012665> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W1966012665 abstract "Prostate cancer (PCa)is the second most frequently diagnosed cancer and the sixth leading cause of cancer death in males, with the highest incidence rates recorded in developed countries such as those in North America (Jemal et al., 2011). While the five year-survival rate for PCa patients with localized disease is 100%, it is only 30.6% once the cancer metastasizes (Vishnu et al., 2010). One of the biggest challenges for finding a better treatment for metastatic PCa is the lack of predictable and accurate preclinical models that closely recapitulate different stages of the pathogenesis of human PCa. Champions Oncology focuses on the development of Champions TumorGraft™ models derived from the direct implantation of patient tumors into immunocompromised mice. Compared to traditional cell line-based xenograft models, the patient-derived TumorGraft models maintain stable gene-expression patterns and mutational status and correlate to clinical predictability. To overcome the challenge for PCa, Champions Oncology has utilized its TumorGraft technology to establish and characterize a new androgen-dependent prostate cancer TumorGraft model, CTG-0488. This involved the implantation of a primary human prostate tumor in immunocompromised mice in a manner that preserves the biological properties of the original human tumor. In this preliminary work, the characteristics of Champion TumorGraft™ model CTG-0488 are showcased, including tumor histology, mutational status, and chemosensitivity profiles to several standard of care compounds. Overall the development of an androgen-dependent prostate cancer Champions TumorGraft™ model will significantly aid in the development of oncology compounds focused on androgen-dependent prostate cancer. Citation Format: Tin Oo Khor, Keren Paz, Dhanrajan Tiruchinapalli, David Sidransky, Elizabeth M. Bruckheimer. Development of an androgen-dependent prostate Champions TumorGraft™ cancer model. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 2793. doi:10.1158/1538-7445.AM2013-2793" @default.
- W1966012665 created "2016-06-24" @default.
- W1966012665 creator A5020667709 @default.
- W1966012665 creator A5048515583 @default.
- W1966012665 creator A5049209796 @default.
- W1966012665 creator A5071371829 @default.
- W1966012665 creator A5071391683 @default.
- W1966012665 date "2013-04-15" @default.
- W1966012665 modified "2023-09-25" @default.
- W1966012665 title "Abstract 2793: Development of an androgen-dependent prostate Champions TumorGraft™ cancer model." @default.
- W1966012665 doi "https://doi.org/10.1158/1538-7445.am2013-2793" @default.
- W1966012665 hasPublicationYear "2013" @default.
- W1966012665 type Work @default.
- W1966012665 sameAs 1966012665 @default.
- W1966012665 citedByCount "0" @default.
- W1966012665 crossrefType "proceedings-article" @default.
- W1966012665 hasAuthorship W1966012665A5020667709 @default.
- W1966012665 hasAuthorship W1966012665A5048515583 @default.
- W1966012665 hasAuthorship W1966012665A5049209796 @default.
- W1966012665 hasAuthorship W1966012665A5071371829 @default.
- W1966012665 hasAuthorship W1966012665A5071391683 @default.
- W1966012665 hasConcept C121608353 @default.
- W1966012665 hasConcept C126322002 @default.
- W1966012665 hasConcept C143998085 @default.
- W1966012665 hasConcept C2776235491 @default.
- W1966012665 hasConcept C2777911890 @default.
- W1966012665 hasConcept C2780192828 @default.
- W1966012665 hasConcept C29456083 @default.
- W1966012665 hasConcept C502942594 @default.
- W1966012665 hasConcept C71315377 @default.
- W1966012665 hasConcept C71924100 @default.
- W1966012665 hasConceptScore W1966012665C121608353 @default.
- W1966012665 hasConceptScore W1966012665C126322002 @default.
- W1966012665 hasConceptScore W1966012665C143998085 @default.
- W1966012665 hasConceptScore W1966012665C2776235491 @default.
- W1966012665 hasConceptScore W1966012665C2777911890 @default.
- W1966012665 hasConceptScore W1966012665C2780192828 @default.
- W1966012665 hasConceptScore W1966012665C29456083 @default.
- W1966012665 hasConceptScore W1966012665C502942594 @default.
- W1966012665 hasConceptScore W1966012665C71315377 @default.
- W1966012665 hasConceptScore W1966012665C71924100 @default.
- W1966012665 hasLocation W19660126651 @default.
- W1966012665 hasOpenAccess W1966012665 @default.
- W1966012665 hasPrimaryLocation W19660126651 @default.
- W1966012665 hasRelatedWork W164919769 @default.
- W1966012665 hasRelatedWork W2006027129 @default.
- W1966012665 hasRelatedWork W2037726760 @default.
- W1966012665 hasRelatedWork W2059389875 @default.
- W1966012665 hasRelatedWork W2072165754 @default.
- W1966012665 hasRelatedWork W2074737073 @default.
- W1966012665 hasRelatedWork W2108299465 @default.
- W1966012665 hasRelatedWork W2168372709 @default.
- W1966012665 hasRelatedWork W2170419735 @default.
- W1966012665 hasRelatedWork W2570891610 @default.
- W1966012665 hasRelatedWork W2591093632 @default.
- W1966012665 hasRelatedWork W2613537109 @default.
- W1966012665 hasRelatedWork W2763813218 @default.
- W1966012665 hasRelatedWork W2774755963 @default.
- W1966012665 hasRelatedWork W2922311370 @default.
- W1966012665 hasRelatedWork W2973893673 @default.
- W1966012665 hasRelatedWork W3195441382 @default.
- W1966012665 hasRelatedWork W563161670 @default.
- W1966012665 hasRelatedWork W2707547304 @default.
- W1966012665 hasRelatedWork W2943811121 @default.
- W1966012665 isParatext "false" @default.
- W1966012665 isRetracted "false" @default.
- W1966012665 magId "1966012665" @default.
- W1966012665 workType "article" @default.